Cited in boardrooms, legal proceedings & government briefings since 2017
Poland is expected to play a central role in the European cannabis market in the coming years, after becoming the 12th country to legalise medicinal cannabis on the continent in 2017.
Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.
Trusted by teams at
Poland is expected to play a central role in the European cannabis market in the coming years, after becoming the 12th country to legalise medicinal cannabis on the continent in 2017. A free, citable reference for anyone working on cannabis policy, regulation or market strategy.
delivery format
2019
published
This white paper explores the key developments taking place in the burgeoning Polish cannabis market. The cannabis sector is currently experiencing a boom in Poland, with the medicinal cannabis market expected to be worth at least €2.0 billion by 2028. The bulk of commercial activity centres on industrial hemp, which is legal to cultivate, process, market and consume in Poland. It is illegal to cultivate medical cannabis domes-tically. As a result, the majority of the most lucrative opportunities in the sector are only available to foreign producers of medical cannabis. Recreational cannabis is illegal in Poland. In addition to detailing the latest legislative developments and identifying the activity of key market participants, this white paper provides an overview of the challenges and opportunities facing the cannabis market in Poland today. Current Laws and Regulations Licenses and Availability Healthcare Analysis
Investors & analysts
Defensible sizing and forecasts to underwrite the thesis.
Corporate strategy & FMCG
Opportunity sizing and entry routes across key markets.
